IN BRIEF: Physiomics eyes new contracts but half-year loss widens

Related news

Physiomics PLC - Oxfordshire, England-based mathematical modelling company that supports oncology drug development - Pretax loss widens to £249,000 in the six months to December 31 compared with £235,000 a year prior as revenue dips 12% to £329,000 from £374,000. Highlights strong pipeline with four contracts won in the first half of the financial year. Based on these signed contracts, the company expects total income for the current financial year will be in line with market expectations, with additional contracted revenue projected into next year - year to June 2026. The company is ‘actively progressing’ a number of late-stage opportunities, however, there is no guarantee that these contracts will be signed within the current financial year.

Current stock price: 0.43 pence, down 7.8% in London on Wednesday

12-month change: down 69%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Results

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.